PubMatic (NASDAQ:PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that it has entered into a definitive agreement to acquire Martin, a media measurement and reporting platform, deepening the company’s investment in supply path optimization (SPO).
Eterna Therapeutics And Lincoln Park Capital Enter Into A 2-Year Common Stock Purchase Agreement For Up To $10M
Eterna Therapeutics Inc. (NASDAQ:ERNA) ("Eterna" or the "Company"), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with
